Q&A with Cleary’s Kathleen Bradish

10 February 2019

Kathleen Bradish returned to Cleary Gottlieb Steen & Hamilton as counsel last autumn after almost three-and-a-half years at the Department of Justice’s antitrust division, where she was assistant chief for the international section. She already had nearly a decade of experience at Cleary, where she represented pharmaceutical companies including Santarus, Abbott Laboratories and GlaxoSmithKline. Bradish will be speaking at the inaugural GCR Live Pharmaceuticals conference on 28 February in Washington, DC.

Q&A with Cleary’s Kathleen Bradish